EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

p53 protein expression patterns associated with TP53 mutations in breast carcinoma

Sarah A Anderson, Brooke B Bartow, Shuko Harada, Gene P Siegal, Shi Wei, Valeria L Dal Zotto, Xiao Huang

Breast Cancer Research and Treatment · 2024-08 · 207 (1) · 213-222

DOI: 10.1007/s10549-024-07357-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 20.06.2024. Verfasst von Sarah A Anderson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Alabama at Birmingham, 619 19th Street South, Birmingham, AL, 35294, USA. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Breast Neoplasms, Mutation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The importance of a TP53 mutation has been demonstrated in several tumor types, including breast cancer (BC). However, the accuracy of p53 protein expression as a predictor of gene mutation has not been well studied in BC. Therefore, we evaluated p53 protein expression associated with TP53 mutations in breast cancers from 64 patients.

Methods

TP53 mutation was examined using next-generation sequencing (NGS). p53 protein expression was examined using immunohistochemistry (IHC).

Results

Among the 64 BCs, 55% demonstrated abnormal expression patterns including 27% overexpression, 22% null, 6% equivocal with 45% having a wild-type pattern. A TP53 mutation was present in 53% (34/64) of tumors including 30% (19/64) demonstrating a missense mutation, 11% (7/64) with a frameshift mutation, 11% (7/64) with a nonsense mutation, and 3% (1/64) with a splice site mutation. Abnormal expression of p53 protein was present in 33 of 34 (97%) tumors carrying a TP53 mutation; conversely, a wild-type pattern was present in 28 of 30 (93%) tumors without a detectable mutation ( p < 0.0001). The majority of BCs with a p53 IHC overexpression pattern (15/17, 88%) contained a missense TP53 mutation; while the majority of BCs with a null pattern (12/14, 86%) contained a truncating mutation ( p < 0.0001). The BCs with a null pattern are associated with a high Nottingham histological grade and a triple-negative phenotype when compared to those demonstrating overexpression ( p < 0.05).

Conclusion

These findings suggest that p53 IHC can be a potential surrogate for TP53 mutations in BC. Different p53 expression patterns may correlate with specific TP53 genetic mutations in BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Breast NeoplasmsMutationHumansFemaleMiddle AgedAdultAgedImmunohistochemistryBiomarkers, TumorHigh-Throughput Nucleotide SequencingAged, 80 and over

Stichwörter der Autor:innen

TP53 mutationBreast carcinomap53 immunohistochemistry

Substanzen

Tumor Suppressor Protein p53TP53 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, The University of Alabama at Birmingham, 619 19th Street South, Birmingham, AL, 35294, USA.
  • Department of Pathology, The University of Alabama at Birmingham, 619 19th Street South, Birmingham, AL, 35294, USA. xiaohuang@uabmc.edu.

Zitieren

APA

Anderson, S. A., Bartow, B. B., Harada, S., Siegal, G. P., Wei, S., Dal Zotto, V. L., & Huang, X. (2024). p53 protein expression patterns associated with TP53 mutations in breast carcinoma. Breast Cancer Research and Treatment, 207(1), 213-222. https://doi.org/10.1007/s10549-024-07357-z

Vancouver

Anderson SA, Bartow BB, Harada S, Siegal GP, Wei S, Dal Zotto VL, et al. p53 protein expression patterns associated with TP53 mutations in breast carcinoma. Breast Cancer Research and Treatment. 2024;207(1):213-222. doi:10.1007/s10549-024-07357-z

BibTeX
@article{Anderson2024,
  author = {Anderson, Sarah A and Bartow, Brooke B and Harada, Shuko and Siegal, Gene P and Wei, Shi and Dal Zotto, Valeria L and Huang, Xiao},
  title = {p53 protein expression patterns associated with TP53 mutations in breast carcinoma},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  volume = {207},
  number = {1},
  pages = {213--222},
  doi = {10.1007/s10549-024-07357-z}
}
Kostenlos starten →